Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma

SIMPLE SUMMARY: The introduction of immune checkpoint inhibitors and targeted therapy for the treatment of unresectable advanced or metastatic melanoma has changed the prognosis of melanoma patients. Five-year overall survival rates for metastatic melanoma have increased from less than 10% up to 40–...

Descripción completa

Detalles Bibliográficos
Autores principales: Comito, Francesca, Pagani, Rachele, Grilli, Giada, Sperandi, Francesca, Ardizzoni, Andrea, Melotti, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773625/
https://www.ncbi.nlm.nih.gov/pubmed/35053435
http://dx.doi.org/10.3390/cancers14020271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773625/
https://www.ncbi.nlm.nih.gov/pubmed/35053435
http://dx.doi.org/10.3390/cancers14020271

Ejemplares similares